Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2004 Summer Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2004 Summer Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Therapy of experimental allergic encephalomyelitis under circumstances relevant to human multiple sclerosis

    Wiehagen, Karla
    Bell, J.
    Ellis, Jason Scott, 1977-
    Zaghouani, Habib
    View/Open
    [PDF] TherapyExperimentalAllergicEncephalomyelitis.pdf (10.09Kb)
    Date
    2004
    Contributor
    University of Missouri-Columbia. Office of Undergraduate Research
    Format
    Presentation
    Metadata
    [+] Show full item record
    Abstract
    Experimental allergic encephalomyelitis (EAE) is an inflammatory disease of the central nervous system (CNS) that resembles human multiple sclerosis (MS). EAE and MS develop when proteins of the myelin sheath that covers axons are released and encounter cells of the immune system such as T lymphocytes. Activation of these lymphocytes will trigger inflammation that destroys the myelin leading to clinical signs that manifest mostly in the form of motion impairment and muscle paralysis. Inactivation of myelin specific lymphocytes is currently viewed as a means to halt immune attack against the brain and reverse the course of disease. In this study we devised an antigen specific approach against EAE and tested its efficacy in an advanced genetic setting, which would better represent the human genetic polymorphism. Therefore, we have created an F1(SJL/J x Bl/6) mouse for analysis of the reversal of compatible as well as “in trans” EAE where the disease is induced by a peptide restricted to one parent and the treatment uses a fusion protein carrying a peptide restricted to the other parent. The results indicate that the effectiveness of the treatment depends on the method of disease induction and the genetic makeup of the mouse.
    URI
    http://hdl.handle.net/10355/2047
    Part of
    2004 Summer Undergraduate Research and Creative Achievements Forum (MU)
    Collections
    • 2004 Summer Undergraduate Research and Creative Achievements Forum (MU)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems